Application no. and date | 01912069.0 (espacenet) (Federated) (European Patent Register), 20010319 | Patent/reg. no. and date | DK/EP 1268453, 20060719 | Publication date | 20030102 | Priority no. and date | US 267198 P, 20000407 | EP pub. no. and date |
EP 1268453 20030102 | Effective date | | Applicant/owner | Pfizer Products Inc., Eastern Point Road
Groton,
Connecticut 06340, US | Applicant ref. no. | P11776 DK | Inventor | DAY, W. W.
Pfizer Global Res. & Development, Eastern Point Road
Groton, CT 06340, US, JOHNSON, K. A.
Pfizer Global Res. & Development, Eastern Point Road
Groton, CT 06340, US, PRAKASH, C. A.
Pfizer Global Res. & Development, Eastern Point Road
Groton, CT 06340, US, EGGLER, J. F.
Pfizer Global Res. & Development, Eastern Point Road
Groton, CT 06340, US | Representative | Zacco Denmark A/S, Arne Jacobsens Allé 15, 2300 København S | Opponent | | IPC Class | A61K 31/195 (2006.01) , A61K 31/40 (2006.01) , C07C 229/12 (2006.01) , C07D 207/26 (2006.01) , C07D 295/08 (2006.01) | Title | Østrogen agonist/antagonist metabolitter | Int. application no. | IB2001000427 | Int. publication no. | WO2001077093 | Related patent (certificate) | | Status | Bortfaldet | Pædiatrisk forlængelse | - | Udløbsdato for pædiatrisk forlængelse | - |
|